India's retail inflation based on Consumer Price Index (CPI) continued northward journey...
Chief Economic Advisor (CEA) Krishnamurthy V. Subramanian has said that the Indian...
SRF has entered into a definitive agreement to sell its Engineering Plastics Business to...
NIIT Technologies has concluded the sale of 88.99% equity shares in ESRI India Technologies,...
United Bank of India has received approval to raise equity capital not exceeding Rs 1,500...
Credit Rating Agency Crisil has downgraded Dewan Housing Finance Corporation's commercial...
30-Nov2017
Panacea Biotec's abbreviated new drug application (ANDA) submitted under section 505(j) of the Federal Food, Drug and Cosmetic Act (FD&C Act) for Paclitaxel Protein Bound Particles for injectable Suspension, 100mg/vial has been accepted for filing by the US Food and Drug Administration (FDA).
This product is the generic version of Abraxane, marketed for the treatment of Metastatic Breast Cancer, Non-Small Cell Lung Cancer and Adenocarcinoma of the Pancreas in the US market. The annual sale of Abraxane worldwide is approximately $973.4 million and approximately $633.8 million in the US.
The company has already commercialized this product in India and emerging markets like Sri Lanka, Turkey etc. under the trademark - PacliALL. The company looks forward to commercializing this product in US and several other markets worldwide in collaboration with Apotex.
Panacea Biotec is a leading biotechnology company with established research, manufacturing and marketing capabilities. It is one of the largest vaccine producers and leading Biotechnology Companies in India.
NIIT Technologies has concluded the sale of 88.99% equity shares in ESRI India Technologies, India to Environment Systems Research Institute Inc., USA. Consequent to above sale, ESRI India Technologies,......
United Bank of India has received approval to raise equity capital not exceeding Rs 1,500 crore in one or more tranches during the financial year by way of Qualified Institutions Placement, Public Issue,......
Credit Rating Agency Crisil has downgraded Dewan Housing Finance Corporation's commercial paper worth Rs 850 crore from A3+ to A4+. Its rating also continues to be on 'Rating Watch with Negative Implications'.......
SRF has entered into a definitive agreement to sell its Engineering Plastics Business to DSM, the Life Sciences and Materials Sciences Company in an all-cash transaction, amounting to Rs 320 crore. The......